BECTON, DICKINSON AND COMPANY Line of Credit Facility, Maximum Borrowing Capacity
BECTON, DICKINSON AND COMPANY (BDX) had Line of Credit Facility, Maximum Borrowing Capacity of $3.25 billion as of 2025-09-30, per its 10-K filed 2025-11-25.
Financial Statements › Notes › Debt
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2025-11-25
- 2025-09-30: Line of Credit Facility, Maximum Borrowing Capacity $3.25B.
- 2024-09-30: Line of Credit Facility, Maximum Borrowing Capacity $3.25B.
- 2023-01-31: Line of Credit Facility, Maximum Borrowing Capacity $3.25B.
- 2022-09-30: Line of Credit Facility, Maximum Borrowing Capacity $3.25B.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2025-09-30 | $3.25B 10-K · filed 2025-11-25 |
| 2024-09-30 | $3.25B 10-K · filed 2024-11-27 |
| 2023-01-31 | $3.25B 10-K · filed 2023-11-21 |
| 2022-09-30 | $3.25B 10-K · filed 2022-11-22 |
| 2021-09-30 | $3.25B 10-K · filed 2021-11-24 |
| 2020-09-30 | $2.75B 10-K · filed 2020-11-25 |
| 2019-09-30 | $2.75B 10-K · filed 2019-11-27 |
| 2018-09-30 | $2.75B 10-K · filed 2018-11-21 |
| 2014-09-30 | $1.50B 8-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |